Gilead Sciences, Inc. (GILD) — Financial statements
Income statement, balance sheet, and cash flow for Gilead Sciences, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 29,442↑2.4% | 28,754↑6.0% | 27,116↓0.6% | 27,281↓0.1% | 27,305 | |
| Cost of Revenue | 6,234↓0.3% | 6,251↓3.8% | 6,498↑14.9% | 5,657↓14.3% | 6,601 | |
| Gross Profit | 23,208↑3.1% | 22,503↑9.1% | 20,618↓4.7% | 21,624↑4.4% | 20,704 | |
| Operating Expenses | ||||||
| R&D Expenses | 5,799↓1.8% | 5,907↑3.3% | 5,718↑14.9% | 4,977↑8.2% | 4,601 | |
| General & Administrative Expenses | 2,186↓17.1% | 2,638↓6.4% | 2,818↓42.4% | 4,895↑8.5% | 4,511 | |
| Selling & Marketing Expenses | 3,522↑2.0% | 3,453↑5.5% | 3,272↑320.6% | 778↑5.9% | 735 | |
| SG&A Expenses | 5,708↓6.3% | 6,091↑0.0% | 6,090↑7.4% | 5,673↑8.1% | 5,246 | |
| Other Expenses | 0.00↓100.0% | 8,843↑633.9% | 1,205↓66.9% | 3,644↑288.1% | 939 | |
| Operating Expenses | 11,507↓44.8% | 20,841↑60.2% | 13,013↓9.0% | 14,294↑32.5% | 10,786 | |
| Total Costs & Expenses | 17,741↓34.5% | 27,092↑38.9% | 19,511↓2.2% | 19,951↑14.7% | 17,387 | |
| Operating Results | ||||||
| Operating Income | 11,701↑604.0% | 1,662↓78.1% | 7,605↑3.8% | 7,330↓26.1% | 9,918 | |
| Depreciation & Amortization | 2,760↓0.3% | 2,767↑2.7% | 2,693↑28.1% | 2,103↑2.6% | 2,050 | |
| EBITDA | 13,580↑206.3% | 4,434↓57.8% | 10,496↑18.6% | 8,852↓21.9% | 11,329 | |
| EBIT | 10,820↑549.1% | 1,667↓78.6% | 7,803↑15.6% | 6,749↓27.3% | 9,279 | |
| Interest & Other Income | ||||||
| Net Interest Income | -675↑3.0% | -696↓22.5% | -568↑31.5% | -829↑17.2% | -1,001 | |
| Interest Income | 349↑24.2% | 281↓25.3% | 376↑254.7% | 106 | 0.00 | |
| Interest Expense | 1,024↑4.8% | 977↑3.5% | 944↑1.0% | 935↓6.6% | 1,001 | |
| Non-Operating Income | 881↑17720.0% | -5↑97.5% | -198↓134.1% | 581↓9.1% | 639 | |
| Other Income / Expenses | -1,905↓96.0% | -972↓30.3% | -746↑50.8% | -1,516↑7.6% | -1,640 | |
| Income Before Tax | 9,796↑1319.7% | 690↓89.9% | 6,859↑18.0% | 5,814↓29.8% | 8,278 | |
| Income Tax Expense | 1,286↑509.5% | 211↓83.1% | 1,247↓0.1% | 1,248↓39.9% | 2,077 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 8,510↑1676.6% | 479↓91.5% | 5,612↑22.9% | 4,566↓26.4% | 6,201 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 8,510↑1672.9% | 480↓91.5% | 5,665↑23.4% | 4,592↓26.2% | 6,225 | |
| Bottom-Line Net Income | 8,510↑1672.9% | 480↓91.5% | 5,665↑23.4% | 4,592↓26.2% | 6,225 | |
| EPS (Basic) | 6.84↑1700.0% | 0.38↓91.6% | 4.54↑24.0% | 3.66↓26.2% | 4.96 | |
| EPS (Diluted) | 6.78↑1684.2% | 0.38↓91.6% | 4.50↑23.6% | 3.64↓26.2% | 4.93 | |
| Weighted Average Shares | 1,244↓0.2% | 1,247↓0.1% | 1,248↓0.6% | 1,255↓0.1% | 1,256 | |
| Weighted Average Diluted Shares | 1,255↑0.0% | 1,255↓0.2% | 1,258↓0.3% | 1,262↑0.0% | 1,262 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.